New criteria for Alzheimer's diagnosis allows for preclinical treatment

10/12/2010 | Yahoo!

International Alzheimer's disease experts are suggesting that patients who have episodic memory impairment along with at least one positive biomarker be diagnosed with the disease. The new criteria for diagnosis would allow more patients to get treatment or qualify for clinical trials. "There is no longer a reason to wait until patients have developed full-blown dementia," said Bruno Dubois, leader of the International Working Group for New Research Criteria for the Diagnosis of Alzheimer's Disease.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN